Skip to main content

Articles

Recent Articles

Information from LabCorp about coronavirus disease 2019 (COVID-19)
Articles  —  19 March Mar 2020
Oncology

Information from LabCorp about coronavirus disease 2019 (COVID-19)

Read More about Information from LabCorp about coronavirus disease 2019 (COVID-19)
Information from LabCorp about coronavirus disease 2019 (COVID-19)
Articles  —  19 March Mar 2020
Oncology

Information from LabCorp about coronavirus disease 2019 (COVID-19)

Read More about Information from LabCorp about coronavirus disease 2019 (COVID-19)
ATMP Potency Assay Strategies: Adding Value to Your Asset and Avoiding Delays in Development
Articles  —  28 February Feb 2020
Oncology

ATMP Potency Assay Strategies: Adding Value to Your Asset and Avoiding Delays in Development

Read More about ATMP Potency Assay Strategies: Adding Value to Your Asset and Avoiding Delays in Development
ATMP Potency Assay Strategies: Adding Value to Your Asset and Avoiding Delays in Development
Articles  —  28 February Feb 2020
Oncology

ATMP Potency Assay Strategies: Adding Value to Your Asset and Avoiding Delays in Development

Read More about ATMP Potency Assay Strategies: Adding Value to Your Asset and Avoiding Delays in Development
Evaluating New Antiviral and Antibiotic Drug Candidates
Articles  —  18 February Feb 2020
Oncology

Evaluating New Antiviral and Antibiotic Drug Candidates

Read More about Evaluating New Antiviral and Antibiotic Drug Candidates
Evaluating New Antiviral and Antibiotic Drug Candidates
Articles  —  18 February Feb 2020
Oncology

Evaluating New Antiviral and Antibiotic Drug Candidates

Read More about Evaluating New Antiviral and Antibiotic Drug Candidates
The Evolution of Open-Label Extensions and Rare Disease Studies
Articles  —  18 February Feb 2020
Oncology

The Evolution of Open-Label Extensions and Rare Disease Studies

Read More about The Evolution of Open-Label Extensions and Rare Disease Studies
The Evolution of Open-Label Extensions and Rare Disease Studies
Articles  —  18 February Feb 2020
Oncology

The Evolution of Open-Label Extensions and Rare Disease Studies

Read More about The Evolution of Open-Label Extensions and Rare Disease Studies
Pharmacovigilance Risk Management for Biosimilars
Articles  —  12 February Feb 2020
Oncology

Pharmacovigilance Risk Management for Biosimilars

Read More about Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
Articles  —  12 February Feb 2020
Oncology

Pharmacovigilance Risk Management for Biosimilars

Read More about Pharmacovigilance Risk Management for Biosimilars
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Participation
Articles  —  9 January Jan 2020
Oncology

Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Participation

Read More about Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Participation
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Participation
Articles  —  9 January Jan 2020
Oncology

Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Participation

Read More about Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Participation